Fny Investment Advisers, LLC Athenex, Inc. Transaction History
Fny Investment Advisers, LLC
- $237 Million
- Q2 2025
A detailed history of Fny Investment Advisers, LLC transactions in Athenex, Inc. stock. As of the latest transaction made, Fny Investment Advisers, LLC holds 25 shares of ATNX stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25Holding current value
$0% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding ATNX
# of Institutions
3Shares Held
1.46MCall Options Held
0Put Options Held
0About Athenex, Inc.
- Ticker ATNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 156,790,000
- Market Cap $1.57M
- Description
- Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...